NVST - Envista Holdings Corp Stock Price, Fair Value and News

$20.45+0.27 (+1.34%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

NVST Price Action

Last 7 days

-2.6%

Last 30 days

1.8%

Last 90 days

-1.6%

Trailing 12 Months

-7.0%

NVST RSI Chart

NVST Valuation

Market Cap

3.4B

Price/Earnings (Trailing)

219.77

Price/Sales (Trailing)

1.28

EV/EBITDA

15.86

Price/Free Cashflow

12.81

NVST Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NVST Fundamentals

NVST Revenue

Revenue (TTM)

2.6B

Rev. Growth (Yr)

11.46%

Rev. Growth (Qtr)

-1.79%

NVST Earnings

Earnings (TTM)

15.3M

Earnings Growth (Yr)

-469.51%

Earnings Growth (Qtr)

-214.77%

NVST Profitability

EBT Margin

5.95%

Return on Equity

0.5%

Return on Assets

0.27%

Free Cashflow Yield

7.81%

NVST Investor Care

Buy Backs (1Y)

4.46%

Diluted EPS (TTM)

0.09

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	2.5B	2.6B	2.6B	0
2024	2.6B	2.5B	2.5B	2.5B
2023	2.6B	2.6B	2.6B	2.6B
2022	2.5B	2.5B	2.6B	2.6B
2021	2.1B	2.4B	2.5B	2.5B
2020	2.5B	2.1B	2.0B	1.9B
2019	2.8B	2.8B	2.8B	2.8B
2018	2.8B	2.8B	2.8B	2.8B
2017	0	0	0	2.8B
2016	0	0	0	2.8B

Get all data in R, Python etc through our Historical Stock Data APIs

About Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

CEO	Mr. Amir Aghdaei
WEBSITE	https://envistaco.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	12700

Envista Holdings Corp Frequently Asked Questions

What is the ticker symbol for Envista Holdings Corp? What does NVST stand for in stocks?

NVST is the stock ticker symbol of Envista Holdings Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Envista Holdings Corp (NVST)?

As of Wed Dec 03 2025, market cap of Envista Holdings Corp is 3.36 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NVST stock?

You can check NVST's fair value in chart for subscribers.

Is Envista Holdings Corp a good stock to buy?

The fair value guage provides a quick view whether NVST is over valued or under valued. Whether Envista Holdings Corp is cheap or expensive depends on the assumptions which impact Envista Holdings Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NVST.

What is Envista Holdings Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, NVST's PE ratio (Price to Earnings) is 219.77 and Price to Sales (PS) ratio is 1.28. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVST PE ratio will change depending on the future growth rate expectations of investors.